Table 1. Patient demographics and disease characteristics.

CNS, central nervous system.

CharacteristicsNo. of patients (N = 16)%
Age (years)
Baseline BM cytogenetics
Previous allo-SCT
Extramedullary disease
Duration of CR1 (months)
Number of salvage regimens
Refractory to immediate previous therapy
B-ALL tumor burden in the BM before CAR T cell infusion (n = 15)*
  <50% blasts213

*One patient had only gross extramedullary disease (no detectable disease in the BM).